NCT07847801

Brief Summary

This randomized controlled study will compare epidural anesthesia with general anesthesia in women undergoing elective laparoscopic hysterectomy. A total of 70 participants will be randomly assigned to receive either epidural anesthesia or general anesthesia. The main aim of the study is to determine whether the type of anesthesia affects respiratory function after surgery. Respiratory function will primarily be assessed using peak expiratory flow rate (PEFR) before surgery and at 2, 6, and 24 hours after surgery. The study will also compare postoperative pain, opioid consumption, respiratory and hemodynamic parameters, recovery, mobilization, and other perioperative outcomes between the two groups. The researchers aim to determine whether epidural anesthesia may provide an alternative anesthetic approach for selected patients undergoing laparoscopic hysterectomy while maintaining spontaneous breathing.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
12mo left

Started Oct 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

September 29, 2026

Completed
23 days until next milestone

Study Start

First participant enrolled

October 22, 2026

Expected
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 22, 2027

Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 22, 2027

Last Updated

September 29, 2026

Status Verified

September 1, 2026

Enrollment Period

1 year

First QC Date

September 23, 2026

Last Update Submit

September 23, 2026

Conditions

Keywords

Epidural AnesthesiaGeneral AnesthesiaLaparoscopic HysterectomyPostoperative Respiratory FunctionPeak Expiratory Flow RatePostoperative PainOpioid Consumption

Outcome Measures

Primary Outcomes (1)

  • Change in Peak Expiratory Flow Rate (PEFR)

    Peak expiratory flow rate (PEFR), measured in liters per minute (L/min), will be assessed before surgery and at 2, 6, and 24 hours after surgery. The change in PEFR from the preoperative baseline will be compared between the epidural anesthesia and general anesthesia groups

    Preoperative baseline and 2, 6, and 24 hours after surgery

Study Arms (2)

Epidural Anesthesia

EXPERIMENTAL

Participants assigned to this arm will receive epidural anesthesia via a lumbar epidural catheter. An initial dose of 10 mL of 0.5% bupivacaine with 50 mcg fentanyl will be administered, followed by incremental doses of 2-3 mL of 0.5% bupivacaine every 5 minutes as required to achieve a T4 sensory block, up to approximately 20 mL. Spontaneous ventilation will be maintained. Dexmedetomidine will be administered at 0.2 mcg/kg/h for sedation. Conversion to general anesthesia will be performed if the epidural block is inadequate, the participant cannot tolerate the procedure, or conversion is clinically required.

Procedure: epidural anesthesia

General Anesthesia

ACTIVE COMPARATOR

Participants assigned to this arm will receive standard general anesthesia. Anesthesia will be induced with propofol 2-2.5 mg/kg, fentanyl 1-2 mcg/kg, and rocuronium 0.6 mg/kg, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation, with end-tidal carbon dioxide maintained between 35 and 40 mmHg.

Procedure: General Anesthesia (GA)

Interventions

pidural anesthesia will be administered via a lumbar epidural catheter using 0.5% bupivacaine and fentanyl. Incremental epidural doses will be administered to achieve an adequate sensory block. Spontaneous ventilation will be maintained, and dexmedetomidine will be used for sedation.

Epidural Anesthesia

General anesthesia will be induced with intravenous propofol, fentanyl, and rocuronium, followed by endotracheal intubation. Anesthesia will be maintained with sevoflurane and controlled mechanical ventilation.

General Anesthesia

Eligibility Criteria

Age18 Years - 70 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Female patients aged 18-70 years
  • American Society of Anesthesiologists (ASA) physical status I-III
  • Body mass index (BMI) ≤30 kg/m²
  • Scheduled for elective laparoscopic total hysterectomy
  • Willing and able to provide informed consent

You may not qualify if:

  • Contraindication to neuraxial anesthesia
  • Severe cardiopulmonary disease
  • BMI \>30 kg/m²
  • Pre-existing neurological disorder
  • Inability to cooperate with the study procedures
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kutahya City Hospital

Kütahya, Kütahya, 43100, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Anesthesia, EpiduralAnesthesia, General

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Anesthesia, ConductionAnesthesiaAnesthesia and Analgesia

Study Officials

  • Sabiha Başarı, MD

    Kutahya City Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sabiha Başarı, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to either the epidural anesthesia group or the general anesthesia group. Each participant will receive only the intervention assigned to their group.
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Anaesthesiology and Intensive Care Specialist

Study Record Dates

First Submitted

September 23, 2026

First Posted

September 29, 2026

Study Start (Estimated)

October 22, 2026

Primary Completion (Estimated)

October 22, 2027

Study Completion (Estimated)

October 22, 2027

Last Updated

September 29, 2026

Record last verified: 2026-09

Data Sharing

IPD Sharing
Will share

De-identified individual participant data that underlie the results reported in the published article may be shared upon reasonable request to the corresponding author.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Beginning 6 months after publication of the study results and available for 5 years.
Access Criteria
De-identified individual participant data underlying the published results may be made available to qualified researchers upon reasonable request to the corresponding author. Requests should include a scientifically sound research proposal. Data will be shared only after review and approval of the request and in accordance with applicable ethical and data protection requirements.

Locations